ライフサイエンス出版株式会社

FacebookTwitterInstagram
menu

Japanese Pharmacology & Therapeutics(JPT)

Vol. 30 No. 9 2002

■ SERIES

Japanese clinical trials and frameworks for evaluation

S.Ono

Jpn Pharmacol Ther 2002 30(9)629

■ ORIGINAL ARTICLES

A double blind comparison of efficacy and safety of BIBR277 (Telmisartan), the long-acting angiotensinII AT1 receptor antagonist, and enalapril maleate in patients with mild-to-moderate essential hypertension
─Multicenter, randamised, double-blind study ─

K. Arakawa, et al.

Jpn Pharmacol Ther 2002 30(9)639


Efficacy and safety of an angiotensin II AT1 receptor antagonist, BIBR277 (Telmisartan), in patients with chronic heart failure
─Pilot study─

S. Sasayama, et al.

Jpn Pharmacol Ther 2002 30(9)661


Clinical evaluation of Pariet 10 mg tablets in patients with gastric ulcer diseases

K. Saigenji, et al.

Jpn Pharmacol Ther 2002 30(9)675


Clinical pharmacokinetic study of the ultrasound contrast agent YM454

M. Ohto, et al.

Jpn Pharmacol Ther 2002 30(9)695


Pharmacological properties of azelnidipine, a long-acting calcium channel blocker with high-affinity for vascular tissues (Part 1)─Calcium-channel blocking actions in receptor binding and isolated blood vessel studies─

T. Sada, et al.

Jpn Pharmacol Ther 2002 30(9)703


Pharmacological properties of azelnidipine, a long-acting calcium channel blocker with high-affinity for vascular tissues (Part 2)
─Antihypertensive effects and pharmacokinetics in spontaneously hypertensive rats (SHR)─

T. Sada, et al.

Jpn Pharmacol Ther 2002 30(9)711


Antiatherosclerotic effects of azelnidipine, a long-acting and lipophilic Ca channel blocker, in cholesterol-fed rabbits

T. Sada, et al.

Jpn Pharmacol Ther 2002 30(9)721

■ TOPICS:Asian Clinical Pharmacology Forum in the New Millennium

Present and future of clinical pharmacology in Taiwan

HD. Chern

Jpn Pharmacol Ther 2002 30(9)759


Present and future of clinical pharmacology in Korea

SG. Shin

Jpn Pharmacol Ther 2002 30(9)761


Clinical pharmacology in Singapore
─Current status and future developments─

EJD. Lee

Jpn Pharmacol Ther 2002 30(9)763


The current status and perspective of clinicalpharmacology in Japan

K. Ohashi

Jpn Pharmacol Ther 2002 30(9)765


Paradigm shift of clinical development in Japan & Korea and China current situation

K. Nakamura

Jpn Pharmacol Ther 2002 30(9)767


Panel Discussion

Jpn Pharmacol Ther 2002 30(9)771